PROVIDER PROFILE · NPI 1740256908

Michael NaarendorpM.D.

RheumatologyNew York, NYI

MEDICARE UTILIZATION · PART B · 2024

Total beneficiaries

102

Unique beneficiaries

—

Total services

254

Distinct HCPCS

Medicare payment

$23K

Peer benchmark

Total Medicare services vs. 402 Rheumatology providers in NY — above median (cohort median 1,221).

PRESCRIBING · PART D · 2024

Total Rx claims

4,420

Beneficiaries

—

Total drug cost

$4.4M

Distinct drugs

Brand share

41.9%

Top prescribed drugs

Methotrexate Sodium692 claims

Prednisone387 claims

Gabapentin314 claims

Hydroxychloroquine Sulfate280 claims

Ergocalciferol (Vitamin D2)274 claims

QUALITY · MIPS · 2024

No data available for this provider in 2024.

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

Total received

$4K

Payment records

161

By payment type

Food and Beverage$4K

Education$18

Top paying entities

Food and Beverage$4K

Education$18

REFERRAL NETWORK

Where Michael Naarendorp's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 3 inbound referrers · 0 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
CRESCENDO BIOSCIENCE, INC	52	183
Laboratory Corporation Of America Holdings Clinical Laboratory · Raritan, NJ	18	46
ST LUKES ROOSEVELT HOSPITAL CENTER	15	62

Refers patients to

Outbound — where patients go next

No outbound pairs above the suppression threshold.

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history